The new study, published in the journal Science Advances, suggests that BCG could potentially act to inhibit the biomarkers of inflammation by the immune cells in the blood.
According to the lead researcher of the study, there is an urgent need to study the association of COVID-19 with dormant TB reactivation to avoid a potential global TB pandemic.
The new research was published in the Clinical Infectious Diseases journal published by Oxford University Press, London in its latest edition.
The COVID-19 fatality rate in the state has remained low at 0.5 per cent. But those with comorbid conditions like diabetes, cancer, and chronic respiratory illnesses are at a larger risk.
It is because the infecting organism, Mycobacterium tuberculosis, is likely dead, wiped out naturally by people's immune systems, a new study suggests.
The 76-year-old star, who has been associated with various health campaigns like Polio, Hepatitis B, Tuberculosis and diabetes, urged people to get tested and diagnosed.
Tuberculosis, which is caused by a bacterium called Mycobacterium Tuberculosis, affects more than 10 million people every year.
Delamanid would be introduced in UP in the third quarter of the year, as per the central guidelines, according UP state health officials.
Experiments showed that within five days after infection, ILC3 cells show up in the lungs, where they release chemical compounds that activate and attract other immune cells.